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ABSTRACT  
Aim: Maternal obesity is associated with significant pregnancy complications and is a risk 
factor for the development of hypertensive disorders of pregnancy as well as other adverse 
outcomes. There are few data regarding the hemodynamic aberrations observed in maternal 
obesity. The aim of this study was to investigate maternal hemodynamics in morbidly obese 
pregnant women. 
Methods: This was a prospective, case-control study of morbidly obese women (BMI 
>40kg/m2) and controls (BMI 20-29.9 kg/m2) at a ratio of one-to-ten. The control population 
was matched for maternal age and gestational age. BMI was calculated based on maternal 
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height and weight at the time of recruitment to the study, which occurred on the same day as 
the hemodynamic assessment. Pregnant women in the second or third trimester of 
pregnancy were included. Women who were found to be hypertensive at any time were 
excluded from the study. USCOM-1A® was used to assess hemodynamic parameters (heart 
rate, stroke volume, cardiac output and systemic vascular resistance). The parameters were 
corrected for body surface area (BSA) to provide the stroke volume index (SVI), cardiac 
index (CI) and systemic vascular resistance index (SVRI). Mann Whitney-U test was used to 
compare the medians of the hemodynamic variables between the two groups. 
Results: A total of 30 obese women and 327 controls were recruited. There was no 
difference in maternal (p=0.506) or gestational (p=0.693) age at recruitment between the 
groups. Mean arterial pressure was higher both at pregnancy booking (90 vs 80 mmHg, 
p<0.001) and study recruitment (91 vs 85 mmHg, p<0.001) in the obese group. Heart rate 
was higher in the obese group (p=0.003), however there was no difference in stroke volume 
(p=0.271), cardiac output (p=0.238) or systemic vascular resistance (p=0.635). Following 
correction of these parameters for BSA, the SVI (34 vs 45 ml/m2, p<0.001) and CI (2.96 vs 
3.64 L/min/m2, p<0.001) were significantly reduced in the obese group, whilst the SVRI was 
significantly higher (2354 vs 1840 dynes-sec-cm5/m2, p<0.001).  
Conclusion: The findings of our study suggest that cardiac function is significantly altered in 
morbidly obese pregnant women. In order to make appropriate comparisons between 
individuals, it is imperative that hemodynamic parameters are indexed for BSA – as indeed 
they are in pediatric cardiology. The novel finding of a reduced CI in morbidly obese 
pregnant women may explain the predisposition to preeclampsia and other adverse 
outcomes in this population and warrants further investigation. 
 
 
 
INTRODUCTION 
Obesity is an epidemic, which is associated with heightened perinatal mortality and morbidity 
(1, 2). In the developed world, its prevalence is reaching unprecedented levels. In 2013, 19% 
of women of childbearing age in England were obese, a significant increase from the 
reported prevalence of 12% in 1993 (3). There is a considerable body of evidence that links 
maternal obesity to a higher risk of adverse pregnancy outcomes, including hypertensive 
disorders of pregnancy, diabetes, pregnancy loss, intrapartum complications and maternal 
death (2, 4-6). 
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Normal physiological adaptation to pregnancy includes an increase in heart rate (HR) and 
cardiac output (CO) and a decrease in mean arterial pressure (MAP) and systemic vascular 
resistance (SVR). Structurally, there is significant cardiac remodeling with an increase in left 
ventricular wall mass and chamber size (7).  Maternal obesity is associated with increased 
sympathetic activation resulting in an increase in heart rate, myocardial contractility and 
vasoconstriction, which in turn leads to a raised MAP and SVR. Endothelial cell dysfunction 
caused by the release of pro-inflammatory mediators by adipose tissue is a contributory 
factor to the cardiovascular complications associated with obesity.  
Despite the significant health and economic impact of maternal obesity, there is a paucity of 
good quality studies assessing central hemodynamic parameters in morbidly obese pregnant 
women. The results of published studies have been conflicting with most including small 
sample sizes (8, 9). One reason for this has been the limitation of validated, non-invasive 
tools that can be reliably and safely employed to investigate maternal hemodynamics. Using 
invasive methods, such as thermodilution via a pulmonary artery catheter would be neither 
ethically, nor practically feasible in an obstetric population.  
The majority of published data regarding maternal hemodynamics in morbidly obese 
pregnant women has been using echocardiography, which has been regarded as the widely 
accepted, non-invasive method of choice in the obstetric population. There are no published 
studies in the literature investigating maternal hemodynamics in morbidly obese pregnant 
women using non-invasive methods, other than echocardiography. The main aim of this 
study was to investigate maternal hemodynamics in morbidly obese pregnant women. 
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METHODS 
Study population and recruitment 
This was a prospective, case-control study of 30 morbidly obese pregnant women and 327 
controls. Obesity was defined as a body mass index (BMI) greater than 30kg/m2. Obesity is 
subdivided into classes I (BMI 30-34.9 kg/m2), II (BMI 35-39.9 kg/m2) and III (BMI ≥40 kg/m2) 
(1,2,6,7). Morbid obesity is defined as BMI ≥40 kg/m2 (1,2,7). The controls had a BMI 
between 20-29.9 kg/m2. The control population was matched for maternal age and 
gestational age. We attempted to recruit 10 controls for each obese case (ratio of 1:10). 
Women aged 16 and over with singleton pregnancies were recruited from routine antenatal 
scanning clinics and maternity day assessment unit at our tertiary centre. Women who were 
found to be hypertensive at the time of study recruitment, had a pre-existing diagnosis of 
hypertensive disorders of pregnancy (ISSHP 2014) or congenital / acquired heart disease, 
were excluded from the study. Written consent was obtained from all study participants and 
research ethics committee approval (12/LO/0810) was obtained prior to performing the study 
investigations. Pregnant women in the second or third trimester of pregnancy were invited to 
participate.  
All non-invasive assessments were performed in the same room, under standardized 
conditions for the entire cohort. Maternal height and weight were obtained at study 
recruitment and used to calculate maternal BMI. Following a five-minute period of physical 
inactivity where a medical history was obtained, USCOM-1A® measurements were obtained.   
Subjects in the first and early second trimester (before 20 weeks’ gestation) were assessed 
in a supine position, while those in the late second trimester (after 20 weeks’ gestation) and 
third trimester were in a left lateral position. USCOM-1A® was employed in the flow tracer 
mode (automated tracing of each Doppler profile). For each patient, one Doppler acquisition 
containing a minimum of two Doppler profiles was used for analysis. Measurements were 
obtained on one occasion for each subject. One investigator assessed the quality of each 
Doppler acquisition prior to analysis. If Doppler profiles were deemed to be unsuitable for 
analysis then they were removed, eg noise artefact from valve closure. All researchers 
received formal training on the correct use of the USCOM-1A® device and performed a 
minimum number of training cases prior to study recruitment.  
. 
Research Investigations 
Maternal height, weight and blood pressure were obtained prior to hemodynamic 
assessment. Blood pressure was obtained using an upper arm automatic blood pressure 
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(BP) monitor (Microlife, Microlife AG Swiss Corporation, Switzerland), in a semi-recumbent 
position and using an appropriate sized cuff. USCOM-1A® utilizes continuous wave Doppler, 
with a non-imaging probe in the suprasternal notch to obtain velocity time integrals (VTI) of 
transaortic blood flow at the left ventricular outflow tract. Using an anthropometric algorithm, 
which correlates the outflow tract diameter with the patient’s given height, USCOM-1A® uses 
the VTIs to compute stroke volume (SV) and therefore CO and produce a complete 
hemodynamic profile, including HR, SV, CO and SVR. Each Doppler acquisition used for 
analysis had a minimum of 2 consecutive Doppler profiles (cardiac cycles). Acquisitions with 
the least amount of interference and the best quality VTIs, deemed by the study investigator 
to best represent transaortic blood flow, were obtained in the device’s flowtracer mode. By 
calculating the body surface area (BSA) using examination weight and height, USCOM-1A® 
calculates the indexed hemodynamic variable corrected for BSA. The parameters examined 
include cardiac index (CI), stroke volume index (SVI) and SVR index (SVRI). 
Statistical Analysis  
Categorical data were presented as number and percentage, while continuous data were 
presented as the median and interquartile range (IQR). Continuous data were examined 
using the Shapiro-Wilk test to assess the distribution of data. Chi-Square test, or Fisher’s 
exact test when appropriate, was used to compare the categorical variables.  Mann Whitney-
U test was used to compare the medians of the hemodynamic variables between the two 
groups. A p-value less than 0.05 was deemed statistically significant.  All statistical analysis 
was carried out using IBM SPSS Statistics version 21 (IBM Corporation, Armonk, New York, 
United States).  
 
RESULTS  
A total of 30 women with class 3 maternal obesity were recruited to this study. Seven 
patients were excluded, due to hypertensive disorders of pregnancy (n=5) and poor quality 
USCOM-1A® Doppler acquisitions (n=2). Therefore, a total of 23 cases were included in the 
final analysis. The control group consisted of 327 women. Patients were recruited between 
September 2012 and April 2016. The median gestational age at study recruitment for both 
groups was 31 weeks. The baseline demographic characteristics and pregnancy outcomes 
of the two groups are displayed in Table 1. A summary of the analysis of the hemodynamic 
variables is shown in Table 2.   
There was no difference in maternal age (p=0.506) or gestational age at recruitment 
(p=0.693) between the groups. There was a significant difference in the proportion of 
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Afrocaribbean and Caucasian patients between the obese and control study groups. 
Although differences in hemodynamic parameters between the study groups may be 
attributed to ethnicity, we have shown previously in a much larger prospective study that 
ethnicity does not affect maternal hemodynamic parameters (UOG-2016-0728, in press). 
The MAP was significantly higher, both at booking (90 vs 80 mmHg, p<0.001) and at the 
study recruitment (91 vs 85 mmHg, p<0.001) in the obese group. The examination weight 
(113 vs 70 kg, p<0.001) and BMI (41.3 vs 25.9 kg/m2, p<0.001) were significantly higher in 
the obese group.  
Hemodynamic parameters 
The BSA was unsurprisingly significantly higher in the obese group (p<0.001). Heart rate 
was also higher in the obese group (p=0.003). We found no significant difference between 
SV (p=0.271), CO (p=0.238) or SVR (p=0.635) between the two groups. Following correction 
of the variables for BSA, the SVI (p<0.001) and CI (p<0.001) were significantly reduced in 
the obese group when compared to the control group (Figures 1-2, Table 2). We also found 
a higher SVRI in the obese group (p<0.001) (Figure 3, Table 2). 
 
DISCUSSION 
Summary of study findings 
Morbidly obese pregnant women had significantly higher HR, but there was no difference in 
SV, CO or SVR when compared to the control group. Importantly, once corrected for BSA, 
we found that morbidly obese pregnant women had a significantly lower SVI and CI than the 
control group. We also demonstrated that the obese group had a significantly higher SVRI 
than the control group. 
Interpretation of study findings and comparison with the literature 
Our work suggests an impaired cardiac function in morbidly obese pregnant women when 
compared to non-obese controls. Our work also highlights the importance of correcting for 
BSA when comparing individuals with a wide range of body shapes and sizes – as indeed is 
standard practice in pediatric cardiology.  
Dennis et al. (9) used transthoracic echocardiography to assess the cardiovascular changes 
in a sample of 15 obese women (BMI >30 kg/m2). When compared to a cohort of 40 women 
with a normal BMI, the authors reported no difference in HR, SV, SVR or CO. However, they 
did report an increased left ventricular mass in the obese group. Interestingly, the authors 
did not correct the hemodynamic parameters for BSA. Previous work by Veille (8), 
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investigated eight morbidly obese pregnant women using M-mode echocardiography, but 
showed no difference in CO, or left ventricular function.  In agreement with other studies (10, 
11), we found a significantly higher MAP and HR in our obese group.   
Due to growing interest in non-invasive CO monitoring technology, there have been many 
advances in different modalities within this field. Several non-invasive monitors are 
commercially available, using various techniques such as ultrasound, bioimpedance and 
bioreactance. Our group (12) has shown that USCOM-1A® is a reproducible and repeatable 
device. When assessed against a standard of 2-d transthoracic echocardiography, USCOM-
1A® meets the critical level of a 30% mean percentage difference between two CO 
methodologies, in the third trimester of pregnancy. Our previous work highlights that 
USCOM-1A® can be used as a clinically acceptable alternative to echocardiography in 
advanced pregnancy. Its benefits include the ease with which a hemodynamic profile can be 
obtained, as compared to conventional echocardiography.  
Study limitations and strengths 
The strengths of this study included its novel data, relatively large sample size when 
compared to other published studies, excluding patients that developed adverse pregnancy 
outcomes eliminating the independent bias of these factors on maternal hemodynamics. A 
limitation of this study is that we did not include a non-pregnant morbidly obese group. This 
group could have provided data on the cardiac function in obese women outside of 
pregnancy, and therefore allowed us to evaluate whether cardiac impairment occurs 
independently of, or as a result of, pregnancy. 
Clinical and research implications 
Our work suggests that cardiac function is altered in morbidly obese pregnant women. We 
highlight the need to index hemodynamic variables for BSA in order to make appropriate 
comparisons between individuals with a diverse range of anthropometric parameters. Our 
work demonstrates an adverse cardiovascular profile exhibited by obese pregnant women, 
which would support why obesity is a risk factor for maternal cardiovascular disorders (13, 
14). 
We believe that the increasing prevalence of maternal obesity is a sufficient cause for 
concern to warrant the attention of future research. The current study, whilst suggesting an 
impaired cardiac function, is unable to elucidate structural or functional differences. A 
reduced CI in maternal obesity could be attributable to a number of pathways, including 
diastolic or systolic dysfunction or hypertrophic changes (14, 15). These changes could be 
assessed using echocardiography. Future work should aim to assess whether cardiac 
impairment has a relationship to the amount of weight gained, and therefore extra demand 
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on the cardiovascular system, during the pregnancy. Moreover, prospective large studies are 
needed to determine whether cardiac impairment pre-dates the pregnancy, or occurs as a 
result of the cardiovascular maladaptation to the significant demands of an ongoing 
pregnancy. In order to address these important questions, longitudinal assessment is 
required, both pre-pregnancy and in obese non-pregnant women.   
Conclusion 
Our results demonstrate a reduced SVI and CI, and a higher SVRI in morbid maternal 
obesity. Assessing absolute values without correcting for BSA, does not allow for 
appropriate comparison in an obstetric population, especially in the context of obesity. The 
methodology used in this study has been previously validated and appears to have many 
positive features enabling its use in future clinical and research work. The novel finding of a 
reduced CI in morbidly obese pregnant women may explain the predisposition to 
preeclampsia and other adverse outcomes in this population (13-15). As impaired maternal 
hemodynamics in morbid obesity may not necessarily correlate with cardiac dysfunction, 
further investigation using alternate methodologies to carry out an in-depth assessment of 
structural and functional changes associated with maternal obesity is warranted.  
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Table 1. Baseline characteristics and birth outcomes of the study groups. 
 
 Morbidly Obese 
pregnant 
women (n=23) 
Controls (n=327) p value 
Maternal Age in years, median (IQR) 31 (27-35) 32 (28-38) 0.506 
Gestational age in weeks, median 
(IQR) 
31.5 (27.8-35.1) 31.1 (27.6-34.4) 0.693 
Ethnicity, n (%)    
   Caucasian 9 (39) 228 (69) 0.002 
   Afrocaribbean 9 (39) 33 (10) 0.001 
   Asian 3 (13) 55 (17) 0.779 
   Mixed / Other 2 (9) 11 (3) 0.207 
Assisted Conception, n (%) 0 (0) 14 (4) 0.611 
Nulliparity, n (%) 9 (39) 187 (57) 0.092 
Maternal weight at pregnancy booking 
in kilograms, median (IQR) 
104 (93-118) 61.5 (56-70) <0.001 
Maternal weight at the assessment in 
kilograms, median (IQR) 
113 (103-117) 70 (64-76) <0.001 
Maternal BMI at the hemodynamic 
assessment in kilograms/ m2, median 
(IQR) 
41.3 (40.8-42.9) 25.9 (24.2-27.7) <0.001 
Mode of Delivery, n (%)    
   Spontaneous vaginal 13 (56) 183 (58) 0.883 
   Operative vaginal  2 (9) 61 (19) 0.205 
   Caesarean Section 8 (35) 73 (23) 0.208 
Preterm delivery (<37 weeks), n (%) 1 (4) 8 (2.5) 0.603 
Gestational age at delivery, median 40.3 (37.4-41.5) 40.2 (37.6-41.6) 0.813 
Birthweight in grams, median (IQR) 3470 (3070-3650) 3320 (3100-3624) 0.716 
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Table 2. Maternal non-invasive hemodynamic assessment in the study groups 
 Morbidly Obese 
pregnant women 
(n=23) 
Controls (n=327) p value 
Maternal mean arterial 
pressure at pregnancy 
booking in mmHg, 
median (IQR) 
90 (83-97) 80 (74-86) <0.001 
Maternal mean arterial 
pressure at the 
hemodynamic 
assessment in mmHg, 
median (IQR) 
91 (86-96) 85 (79-91) <0.001 
Body Surface Area in 
m2, median (IQR) 
2.36 (2.23-2.41) 1.82 (1.73-1.91) <0.001 
Heart rate in bpm, 
median (IQR) 
91 (82-101) 82 (73-93) 0.003 
Stroke volume in mls, 
median (IQR) 
79 (67-89) 82 (71-93) 0.271 
Stroke Volume Index in 
mls/m2, median (IQR) 
34 (30-37) 45 (39-51) <0.001 
Cardiac Output in 
L/min, median (IQR) 
7.13 (6.20-7.70) 6.60 (5.80-7.55) 0.238 
Cardiac Index in 
L/min/m2, median (IQR) 
2.96 (2.72-3.30) 3.64 (3.19-4.16) <0.001 
Systemic Vascular 
Resistance in dynes-
sec-cm5, median (IQR) 
1016 (886-1176) 1032 (890-1170) 0.635 
Systemic Vascular 
Resistance Index in 
dynes-sec-cm5/m2, 
median (IQR) 
2354 (2136-2828) 1840 (1601-2145) <0.001 
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FIGURE LEGENDS 
 
Figure 1. Box and whisker plot of the stroke volume index in the two study groups. The 
horizontal line in the box represents the median, the box represents the interquartile range 
and the whiskers indicate the minimum and maximum values. 
  
 
Figure 2. Box and whisker plot of the cardiac index in the two study groups. The horizontal 
line in the box represents the median, the box represents the interquartile range and the 
whiskers indicate the minimum and maximum values. 
 
 
Figure 3. Box and whisker plot of the systemic vascular resistance index in the two study 
groups. The horizontal line in the box represents the median, the box represents the 
interquartile range and the whiskers indicate the minimum and maximum values. 
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